Study Opens a New, Additional Area of Development for Istaroxime WARRINGTON, Pa., Oct. 1, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that it has dosed the first patient in its Phase 2 […]
Author: Ken Dropiewski
El Camino Health First in State to be Recognized for Excellence with Transcatheter Valve Certification
Builds upon health system’s leadership in cardiology with its newly opened Women’s Heart Center and special Cardio-Oncology Program MOUNTAIN VIEW, Calif., Oct. 1, 2020 /PRNewswire/ — El Camino Health has been recognized with the Transcatheter Valve Certification from the American College of Cardiology (ACC), acknowledging its exceptional program, physician leadership, quality patient outcomes and […]
Dascena Presents Poster Highlighting Machine Learning Algorithm for Earlier Detection of ACS at HFSA Virtual Annual Scientific Meeting
OAKLAND, Calif.–(BUSINESS WIRE)–Dascena, Inc., a machine learning diagnostic algorithm company that is targeting early disease intervention to improve patient care outcomes, today announced that a poster highlighting the ability of a Dascena machine learning algorithm to provide earlier identification of acute coronary syndrome (ACS) is being presented during the Heart […]
Alucent Biomedical Announces $35 Million Series B Financing Led by a Multinational Strategic Investor
Funding Will Support Clinical Trials to Evaluate the Company’s Novel Treatment for Peripheral Artery Disease SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, today announced the close of a $35 million Series B financing round led by a […]
RapidAI Among the First Stroke Imaging Companies with Software Approved for Medicare New Technology Add-on Payment
Stroke Imaging Makes Significant Stride in Reimbursement. Helps U.S. Hospitals More Easily Adopt the Latest Advancements in Stroke Care SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the worldwide leader in advanced imaging for stroke, today announced Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP). […]
AngelMed Announces First Implant of Next-Generation AngelMed Guardian® in the U.S.
The World’s First Implantable Monitor for Early Warning of ACS, Including Heart Attacks EATONTOWN, N.J., Sept. 30, 2020 /PRNewswire/ — AngelMed is pleased to announce that on Tuesday, September 29th, a former ALERTS Study patient in the United States received the first implant of the next-generation AngelMed Guardian® System as part of the ALERTS-Continued Access Study. […]
SentiAR Announces FDA 510K Clearance of CommandEP™ System, the First Holographic Cardiac Ablation Guidance System
ST. LOUIS, Sept. 30, 2020 /PRNewswire/ — SentiAR, a pioneer in visualization technologies for surgical applications announces U.S. Food and Drug Administration (FDA) 510(k) clearance of its groundbreaking CommandEP™ system, the first holographic guidance system to be used during an invasive cardiac procedure. The CommandEP system allows electrophysiologists to visualize 3D electroanatomic models in […]
Medtronic to Acquire Avenu Medical
Avenu’s Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic’s Commitment to Improving Outcomes for Patients with End-Stage Renal Disease DUBLIN, Sept. 30, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of Avenu Medical, a privately held medical […]
Janssen Submits New Drug Application (NDA) to U.S. FDA for UPTRAVI® (selexipag) Injection for Intravenous Use to Treat Pulmonary Arterial Hypertension (PAH)
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2020 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for UPTRAVI® (selexipag) as an injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adults […]
Univest Securities, LLC. Announces Closing of Somulation, Inc. Acquisition and $7 Million Private Placement for its Client Marizyme, Inc. (OTC: MRZM)
New York, Sept. 29, 2020 (GLOBE NEWSWIRE) — Univest Securities, LLC, a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing for the acquisition of Somulation, Inc. by its client Marizyme, Inc. (OTC:MRZM) (“Marizyme” or the “Company”), […]
Recent
Popular
- No commented posts yet